⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11016214 | 0.92 | — | — | |
| SCHEMBL11010223 | 0.90 | — | — | |
| SCHEMBL19957455 | 0.72 | — | — | |
| SCHEMBL10144664 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL8327181 | 0.70 | — | — | |
| SCHEMBL7639495 | 0.69 | — | — | |
| SCHEMBL15182171 | 0.69 | — | — | |
| SCHEMBL8519306 | 0.67 | — | — | |
| SCHEMBL10884472 | 0.67 | CYP2D6 (0.71) | — | |
| SCHEMBL10143141 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4550169-A | ANTITUMOR AND ANTICARCINOGENIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1985-10-29 | — | — | US | claimed |
| EP-2254600-B1 | NOVEL COMPOSITIONS AND USES THEREOF | BIOSUSPENSIONS LTD (GB) | 2017-05-17 | — | — | EP | disclosed |
| US-9254264-B2 | Compositions and uses thereof | BIOSUSPENSIONS LIMITED (GB) | 2016-02-09 | — | — | US | disclosed |
| US-8470873-B2 | Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof | MAST THERAPEUTICS, INC. (US) | 2013-06-25 | — | — | US | disclosed |
| EP-2387991-A1 | Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof | Adventrx Pharmaceuticals, Inc. (US) | 2011-11-23 | — | — | EP | disclosed |
| US-8041772-B2 | Autonomic sensor network ecosystem | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-10-18 | — | — | US | disclosed |
| US-20110117019-A1 | Novel Compositions and Uses Thereof | BIOSUSPENSIONS LIMITED (GB) | 2011-05-19 | — | — | US | disclosed |
| EP-2254600-A1 | NOVEL COMPOSITIONS AND USES THEREOF | Biosuspensions Limited (GB) | 2010-12-01 | — | — | EP | disclosed |
| EP-1730174-B1 | PEPTIDE CARRIER FOR DRUG DELIVERY | UNIV ILLINOIS (US) | 2010-04-21 | — | — | EP | disclosed |
| WO-2009098475-A1 | STRUCTURED SURFACTANT SYSTEMS AND USES THEREOF | BIOSUSPENSIONS LIMITED (GB) | 2009-08-13 | — | — | WO | disclosed |
| EP-1042003-A1 | DELIVERY OF LONG LASTING THERAPEUTIC AGENTS BY FORMING COVALENT ATTACHMENTS IN VIVO | Conjuchem, Inc. (CA) | 2000-10-11 | — | — | EP | disclosed |
| EP-0981328-A1 | EMULSION VEHICLE FOR POORLY SOLUBLE DRUGS | SONUS PHARMACEUTICALS, INC. (US) | 2000-03-01 | — | — | EP | disclosed |
| WO-1999048536-A2 | DELIVERY OF LONG LASTING THERAPEUTIC AGENTS BY FORMING COVALENT ATTACHMENTS IN VIVO | CONJUCHEM, INC. (CA) | 1999-09-30 | — | — | WO | disclosed |
| WO-1998030205-A9 | EMULSION VEHICLE FOR POORLY SOLUBLE DRUGS | — | 1998-12-30 | — | — | WO | disclosed |
| WO-1998030205-A1 | EMULSION VEHICLE FOR POORLY SOLUBLE DRUGS | SONUS PHARMACEUTICALS, INC. (US) | 1998-07-16 | — | — | WO | disclosed |
| US-4816247-A | FOR INJECTIONS | AMERICAN CYANAMID COMPANY (US) | 1989-03-28 | — | — | US | disclosed |
| US-4784845-A | FAT EMULSIONS WITH BENZYL ALCOHOL FOR DRUGS | AMERICAN CYANAMID COMPANY (US) | 1988-11-15 | — | — | US | disclosed |
| EP-0214501-A2 | Emulsion compositions for administration of sparingly water soluble ionizable basic hydrophobic drugs | AMERICAN CYANAMID COMPANY (US) | 1987-03-18 | — | — | EP | disclosed |
| US-4550169-A | ANTITUMOR AND ANTICARCINOGENIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1985-10-29 | — | — | US | disclosed |
| EP-0146711-A2 | 2-hydrazino-1H-imidazoles | AMERICAN CYANAMID COMPANY (US) | 1985-07-03 | — | — | EP | disclosed |